Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

Author:

Robak Tadeusz,Jin Jie,Pylypenko Halyna,Verhoef Gregor,Siritanaratkul Noppadol,Drach Johannes,Raderer Markus,Mayer Jiri,Pereira Juliana,Tumyan Gayane,Okamoto Rumiko,Nakahara Susumu,Hu Peter,Appiani Carlos,Nemat Sepideh,Cavalli Franco,Van Hoof Achiel,Sheliga Adriana,Teixeira Adriana,Tomita Akihiro,Rocafiguera Albert Oriol,Suvorov Alexander,Kuzmin Alexy,Khojasteh Ali,Mezlini Amel,Golenkov Anatoly,Bosly Andre,Belch Andrew,Van De Velde Ann,Illes Árpád,Mukhopadhyay Ashis,Meddeb Balkis,De Prijck Bernard,Garichochea Bernardo,Undar Bulent,Gabarrón Caballero,Cao Carmen,Souza Carmino,Farber Charles,Won Suh Cheol,Burcoveanu Cristina Ileana,Cebotaru Cristina Ligia,Truica Cristina-Ligia,Maruyama Dai,Belada David,Ben Yehuda Dina,Udovitsa Dmitry,Dolores ,Morra Enrica,Späth-Schwalbe Ernst,Gonzalez-Barca Eva,Osmanov Evgenii,Capote Francisco Javier,Offner Fritz,Cardenas Galvez,Heß Georg,Manikhas Georgii,Babu Govind,Rekhtman Grigoriy,Rossi Guiseppe,Marques Herlander,Bumbea Horia,Wang Huaqing,Huang Huiqiang,Choi Ilseung,Bulavina Irina,Lysenko Irina,Avivi Irit,Kryachok Iryna,Zaucha Jan Maciej,Novak Jan,Díaz Joaquín,Demeter Judit,Alexeeva Julia,Zhu Jun,Vilchevskaya Kateryna,Ishizawa Kenichi,Mauricio Kenny,Tobinai Kensei,Ando Kiyoshi,Abdulkadryrov Kudrat,Shih Lee-Yung,Kuzina Lyudmila,Gumus Mahmut,De Wit Maike,Capra Marcelo,Marques Margarida,Golubeva Marina,Ojeda-Uribe Mario,Kyselyova Maryna,Taniwaki Masafumi,Federico Massimo,Crump Michael,Baccarani Michele,Ogura Michinori,Egyed Miklós,Udvardy Miklos,Kurosawa Mitsutoshi,Uike Naokuni,Khuageva Nuriet,Shpilberg Ofer,Gladkov Oleg,Samoilova Olga,Serduk Olga,Santi Patricia,Zachee Pierre,Kaplan Polina,Stoia Razvan,Gressin Remy,Arranz Reyes,Greil Richard,Grosicki Sebastian,Cancelado Sergio,Nair Sreejith,Le Gouill Steven,Van Steenweghen Steven,Yoon Sung-Soo,Chuncharune Suporn,Scheider Tatiana,Shimoyama Tatsu,Liu Ting,Kinoshita Tomohiro,Uchida Toshiki,Bunworasate Udomsak,Vitolo Umberto,Pavlov Viacheslav,Phooshkooru Vijay Rao,Lima Vladimir,Merkulov Vladimir,Nawarawong Weerasak,Hong Xiaonan,Ke Xiaoyan,Terui Yasuhito,Tee Goh Yeow,Maeda Yoshiharu,Shi Yuankai,Dunaev Yuri,Lorie Yurii,Wang Zhao,Shen Zhixiang,Borbenyi Zita,Gasztonyi Zoltán,Masliak Zvenyslava

Publisher

Elsevier BV

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3